Interleukin-17: a potential therapeutic target in COVID-19. Mendoza VMM. J Infect 2020 Jun 3. pii: S0163-4453(20)30350.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mendoza VMM. Interleukin-17: a potential therapeutic target in COVID-19. J Infect 2020 Jun 3. pii: S0163-4453(20)30350.
PMID: 32504739